Extracorporeal Therapy of Sepsis — Target Change
USMU Medical Bulletin · 2025
DOI: 10.52420/usmumb.10.1.e00136 ↗Kurz gefasst
Fachartikel in der Zeitschrift USMU Medical Bulletin, 2025. Verfasst von Vladislav V. Shingur und 1 weiteren Autor:innen.
Themen: Sepsis
Abstract (Originalsprache)
This article reviews current methods of extracorporeal therapy for the treatment of sepsis, with emphasis on innovative hemosorption filters such as Seraph 100 Microbind Affinity, GARNET and Hemopurifier. Sepsis is a serious condition associated with an uncontrolled immune response to infection, often resulting in organ failure and high mortality. Conventional methods, including antimicrobial therapy, may not be sufficient in infections caused by resistant pathogens. Hemosorption filters work by removing pathogens and their mediators from the blood, reducing the risk of cytokine storm and improving clinical outcomes. Studies show the efficacy of these devices in the treatment of complex infections including bacteremia and viremia; however, additional large clinical trials are needed to confirm their safety and optimal indications for use.
Zitieren
APA
Shingur, V. V., & Spichka, I. I. (2025). Extracorporeal Therapy of Sepsis — Target Change. USMU Medical Bulletin. https://doi.org/10.52420/usmumb.10.1.e00136
Vancouver
Shingur VV, Spichka II. Extracorporeal Therapy of Sepsis — Target Change. USMU Medical Bulletin. 2025. doi:10.52420/usmumb.10.1.e00136
BibTeX
@article{Shingur2025,
author = {Shingur, Vladislav V. and Spichka, Igor I.},
title = {Extracorporeal Therapy of Sepsis — Target Change},
journal = {USMU Medical Bulletin},
year = {2025},
doi = {10.52420/usmumb.10.1.e00136}
}
EUVIMED